|
|
 Previous Article | Table of Contents | Next Article 
Treatment of Familial Hemophagocytic Lymphohistiocytosis With Bone Marrow Transplantation From HLA Genetically Nonidentical Donors
Nada Jabado,
Elizabeth R. de Graeff-Meeder,
Marina Cavazzana-Calvo,
Elie Haddad,
Françoise Le Deist,
Malika Benkerrou,
Rémi Dufourcq,
Sophie Caillat,
Stephane Blanche, and
Alain Fischer
From the Unité d'Immuno-Hématologie Pédiatrique, Institut National pour la Santé et la Recherche Medicale U429, and Laboratoire d'immunologie, Hôpital Necker-Enfants Malades, Paris, France; and Department of Pediatrics, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare genetic disorder associated with the onset early in life of overwhelming activation of T lymphocytes and macrophages invariably leading to death. Allogeneic bone marrow transplantation (BMT) from an HLA-identical related donor is the treatment of choice in patients with this disease. However, fewer than 20% of patients have a disease-free HLA-identical sibling. BMT from HLA-nonidentical related donors has previously met with poor results, with graft rejection a major obstacle in all cases. We describe BMTs from HLA-nonidentical related donors (n = 13) and from a matched unrelated donor (n = 1) performed in two centers in 14 consecutive cases of FHL. Remission of disease was achieved before BMT in 10 patients. Marrow was T-cell-depleted to minimize graft-versus-host disease (GVHD). Antiadhesion antibodies specific for the  chain of the leukocyte function-associated antigen-1 (LFA-1, CD11a) and the CD2 molecules were infused pre-BMT and post-BMT to help prevent graft rejection, in addition to a conditioning regimen of busulfan (BU), cyclophosphamide (CP), and etoposide (VP16) or antithymocyte globulin (ATG). Sustained engraftment was obtained in 11 of 17 transplants (3 patients had 2 transplants) and disease-free survival in 9 patients with a follow-up period of 8 to 69 months (mean, 33). Acute GVHD greater than stage I was not observed, and 1 patient had mild cutaneous chronic GVHD that resolved. Toxicity due to the BMT procedure was low. Results obtained using this protocol are promising in terms of engraftment and event-free survival within the limitations of the small sample. We conclude that an immunologic approach in terms of drugs used to obtain disease remission and a conditioning regimen that includes antiadhesion molecules in T-cell-depleted BMT from HLA genetically nonidentical donors is an alternative treatment that warrants further study in FHL patients who lack a suitable HLA genetically identical donor.
Blood, Vol. 90 No. 12 (December 15), 1997:
pp. 4743-4748
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Cesaro, F. Locatelli, E. Lanino, F. Porta, L. Di Maio, C. Messina, A. Prete, M. Ripaldi, N. Maximova, G. Giorgiani, et al.
Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP)
Haematologica,
November 1, 2008;
93(11):
1694 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Santoro, S. Cannella, A. Trizzino, G. Bruno, C. De Fusco, L. D. Notarangelo, D. Pende, G. M. Griffiths, and M. Arico
Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3
Haematologica,
July 1, 2008;
93(7):
1086 - 1090.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Trizzino, U z. Stadt, I Ueda, K Risma, G Janka, E Ishii, K Beutel, J Sumegi, S Cannella, D Pende, et al.
Genotype phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations
J. Med. Genet.,
January 1, 2008;
45(1):
15 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Mahlaoui, M. Ouachee-Chardin, G. de Saint Basile, B. Neven, C. Picard, S. Blanche, and A. Fischer
Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients
Pediatrics,
September 1, 2007;
120(3):
e622 - e628.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Santoro, S Cannella, G Bossi, F Gallo, A Trizzino, D Pende, F Dieli, G Bruno, J C Stinchcombe, C Micalizzi, et al.
Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis
J. Med. Genet.,
December 1, 2006;
43(12):
953 - 960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ouachee-Chardin, C. Elie, G. de Saint Basile, F. Le Deist, N. Mahlaoui, C. Picard, B. Neven, J.-L. Casanova, M. Tardieu, M. Cavazzana-Calvo, et al.
Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 Patients
Pediatrics,
April 1, 2006;
117(4):
e743 - e750.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. S. Lang, M. Recher, A. A. Navarini, S. Freigang, N. L. Harris, M. van den Broek, B. Odermatt, H. Hengartner, and R. M. Zinkernagel
Requirement for Neutralizing Antibodies to Control Bone Marrow Transplantation-Associated Persistent Viral Infection and to Reduce Immunopathology
J. Immunol.,
October 15, 2005;
175(8):
5524 - 5531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Lim and K. S.J. Elenitoba-Johnson
The Molecular Pathology of Primary Immunodeficiencies
J. Mol. Diagn.,
May 1, 2004;
6(2):
59 - 83.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-I. Henter, A. Samuelsson-Horne, M. Arico, R. M. Egeler, G. Elinder, A. H. Filipovich, H. Gadner, S. Imashuku, D. Komp, S. Ladisch, et al.
Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation
Blood,
September 18, 2002;
100(7):
2367 - 2373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Arkwright, M. Abinun, and A. J. Cant
Autoimmunity in human primary immunodeficiency diseases
Blood,
April 15, 2002;
99(8):
2694 - 2702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P SCHNEIDER, V GREENE, J KANOLD, and J-P VANNIER
Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis
Arch. Dis. Child.,
April 1, 2001;
84(4):
373a - 373.
[Full Text]
|
|
|
|
|
|
|
S. Matthes-Martin, C. Peters, A. Konigsrainer, G. Fritsch, T. Lion, A. Heitger, K. Kapelari, M. Kronberger, F. Offner, F. Wrba, et al.
Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis
Blood,
December 1, 2000;
96(12):
3997 - 3999.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nagano, N. Kimura, E. Ishii, N. Yoshida, T. Yoshida, M. Sako, S. Hibi, S. Imashuku, S. Miyazaki, T. Hara, et al.
Clonal Expansion of alpha beta -T Lymphocytes With Inverted Jbeta 1 Bias in Familial Hemophagocytic Lymphohistiocytosis
Blood,
October 1, 1999;
94(7):
2374 - 2382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
